OBJECTIVE: Recent evidence suggests that dendritic cells may play an important role in atherosclerosis. Based primarily on previous in vitro studies, we hypothesized that granulocyte macrophage colony-stimulating factor (GM-CSF)-deficient mice would have decreased dendritic cells in lesions. METHODS AND RESULTS: To test this, we characterized gene targeted GM-CSF(-/-) mice crossed to hypercholesterolemic low-density lipoprotein receptor null mice. Our results provide conclusive evidence that GM-CSF is a major regulator of dendritic cell formation in vivo. Aortic lesion sections in GM-CSF(-/-) low-density lipoprotein receptor null animals showed a dramatic 60% decrease in the content of dendritic cells as judged by CD11c staining but no change in the overall content of monocyte-derived cells. The GM-CSF-deficient mice exhibited a significant 20% to 50% decrease in the size of aortic lesions, depending on the location of the lesions. Other prominent changes in GM-CSF(-/-) mice were decreased lesional T cell content, decreased autoantibodies to oxidized lipids, and striking disruptions of the elastin fibers adjacent to the lesion. CONCLUSION: Given that GM-CSF is dramatically induced by oxidized lipids in endothelial cells, our data suggest that GM-CSF serves to regulate dendritic cell formation in lesions and that this, in turn, influences inflammation, plaque growth and possibly plaque stability.
OBJECTIVE: Recent evidence suggests that dendritic cells may play an important role in atherosclerosis. Based primarily on previous in vitro studies, we hypothesized that granulocyte macrophage colony-stimulating factor (GM-CSF)-deficient mice would have decreased dendritic cells in lesions. METHODS AND RESULTS: To test this, we characterized gene targeted GM-CSF(-/-) mice crossed to hypercholesterolemic low-density lipoprotein receptor null mice. Our results provide conclusive evidence that GM-CSF is a major regulator of dendritic cell formation in vivo. Aortic lesion sections in GM-CSF(-/-) low-density lipoprotein receptor null animals showed a dramatic 60% decrease in the content of dendritic cells as judged by CD11c staining but no change in the overall content of monocyte-derived cells. The GM-CSF-deficient mice exhibited a significant 20% to 50% decrease in the size of aortic lesions, depending on the location of the lesions. Other prominent changes in GM-CSF(-/-) mice were decreased lesional T cell content, decreased autoantibodies to oxidized lipids, and striking disruptions of the elastin fibers adjacent to the lesion. CONCLUSION: Given that GM-CSF is dramatically induced by oxidized lipids in endothelial cells, our data suggest that GM-CSF serves to regulate dendritic cell formation in lesions and that this, in turn, influences inflammation, plaque growth and possibly plaque stability.
Authors: M A Hofmann; S Drury; C Fu; W Qu; A Taguchi; Y Lu; C Avila; N Kambham; A Bierhaus; P Nawroth; M F Neurath; T Slattery; D Beach; J McClary; M Nagashima; J Morser; D Stern; A M Schmidt Journal: Cell Date: 1999-06-25 Impact factor: 41.582
Authors: S Ishibashi; T Inaba; H Shimano; K Harada; I Inoue; H Mokuno; N Mori; T Gotoda; F Takaku; N Yamada Journal: J Biol Chem Date: 1990-08-25 Impact factor: 5.157
Authors: T B Rajavashisth; A Andalibi; M C Territo; J A Berliner; M Navab; A M Fogelman; A J Lusis Journal: Nature Date: 1990-03-15 Impact factor: 49.962
Authors: Sotirios Tsimikas; Joseph L Witztum; Elizabeth R Miller; William J Sasiela; Michael Szarek; Anders G Olsson; Gregory G Schwartz Journal: Circulation Date: 2004-09-07 Impact factor: 29.690
Authors: Mohamad Navab; G M Ananthramaiah; Srinivasa T Reddy; Brian J Van Lenten; Benjamin J Ansell; Gregg C Fonarow; Kambiz Vahabzadeh; Susan Hama; Greg Hough; Naeimeh Kamranpour; Judith A Berliner; Aldons J Lusis; Alan M Fogelman Journal: J Lipid Res Date: 2004-04-01 Impact factor: 5.922
Authors: Atilla Yilmaz; Marlene Lochno; Friedemann Traeg; Iwona Cicha; Christine Reiss; Christian Stumpf; Dorette Raaz; Thomas Anger; Kerstin Amann; Thomas Probst; Josef Ludwig; Werner G Daniel; Christoph D Garlichs Journal: Atherosclerosis Date: 2004-09 Impact factor: 5.162
Authors: Clinton S Robbins; Aleksey Chudnovskiy; Philipp J Rauch; Jose-Luiz Figueiredo; Yoshiko Iwamoto; Rostic Gorbatov; Martin Etzrodt; Georg F Weber; Takuya Ueno; Nico van Rooijen; Mary Jo Mulligan-Kehoe; Peter Libby; Matthias Nahrendorf; Mikael J Pittet; Ralph Weissleder; Filip K Swirski Journal: Circulation Date: 2011-12-05 Impact factor: 29.690